跳至主要内容
临床试验/NCT00856219
NCT00856219已完成1 期

Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects

Rutgers, The State University of New Jersey1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2009年2月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Route and type of feeding on Immune response

研究概览

简要总结

Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune system may respond differently when receiving continuous TF as compared to receiving intermittent TF. Heart rate variability (HRV, the intervals between heartbeats) is a measurement of the nervous system's response to a stress/illness. The differences in immune cells and/or HRV may influence how the body reacts to complications such as infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •General good health as demonstrated by medical history, physical& laboratory tests
  • •Age between 18 and 40 years
  • •Written informed consent prior to the performance of any study related procedures

排除标准

  • •History of cancer, rheumatoid arthritis, or immunological, renal, hepatic, endocrine, neurologic, heart disease or hypertension
  • •Any medication taken in past 48 hrs (except birth control)
  • •Recent history of alcohol or drug abuse
  • •Unable to provide written informed consent
  • •Exposure to any experimental agent or procedure within 30 days of study
  • •Pregnant or breast-feeding

研究组 & 干预措施

Enteral Continuous

Active Comparator

Continuous tube feeding for 72 hours.

干预措施: Enteral Continuous (Dietary Supplement)

Enteral Intermittent

Active Comparator

Intermittent tube feedings for 72 hours

干预措施: Enteral Intermittent (Dietary Supplement)

Parenteral

Active Comparator

Parenteral continuously for 72 hours

干预措施: Parenteral Continuous (Dietary Supplement)

结局指标

主要结局

Route and type of feeding on Immune response

时间窗: Day 1- Day 4

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验